Biohaven price target lowered to $66 from $68 at RBC Capital

3 days ago · RBC Capital lowered the firm’s price target on Biohaven (BHVN) to $66 from $68 and keeps an Outperform rating on the shares. The firm’s price target reduction reflects the …

CouponFollow Extension

$66
OFF

Biohaven Price Target Lowered To $66 From $68 At RBC Capital

1 week from now

3 days ago · RBC Capital lowered the firm’s price target on Biohaven (BHVN) to $66 from $68 and keeps an Outperform rating on the shares. The firm’s price target reduction reflects the …

nasdaq.com

$66
OFF

Biohaven Ltd.: Strong Buy Rating Driven By Promising Pipeline …

1 week from now

3 days ago · Biohaven price target lowered to $66 from $68 at RBC Capital; Biohaven price target raised to $75 from $55 at TD Cowen; Biohaven reports Q3 adjusted EPS ($1.74), consensus …

businessinsider.com

$68.00
OFF

Biohaven Stock Target Cut By Analyst On Model Updates

1 week from now

4 days ago · On Wednesday, RBC Capital adjusted its outlook on Biohaven Pharmaceutical (TADAWUL:2070) Holding (NYSE:BHVN), reducing the stock's price target from $68.00 to …

investing.com

$75
OFF

Biohaven Shares Rise As TD Cowen Lifts Price Target To $75

1 week from now

4 days ago · RBC Capital lowered Biohaven's stock price target from $68.00 to $66.00, maintaining an Outperform rating, following the company's third-quarter earnings report for …

investing.com

$68
OFF

Analysts Offer Insights On Healthcare Companies: Biohaven Ltd.

1 week from now

Oct 9, 2024 · Biohaven price target raised to $68 from $55 at JPMorgan; 3 Best Stocks to Buy Now, 10/3/2024, According to Top Analysts ; ... Biohaven price target lowered to $66 from $68 …

businessinsider.com

$66
OFF

Biohaven Research Stock Price | BHVN Stock Quote, News, And …

1 week from now

Biohaven price target lowered to $66 from $68 at RBC Capital. Historical Prices for Biohaven Research. ... RBC Capital Markets Maintained Buy $59 gut 05/30/24 ...

businessinsider.com

$75
OFF

Biohaven Shares Rise As TD Cowen Lifts Price Target To $75

1 week from now

RBC Capital lowered Biohaven's stock price target from $68.00 to $66.00, maintaining an Outperform rating, following the company's third-quarter earnings report for 2024.

investing.com

$66
OFF

RBC Cuts Price Target On Biohaven To $66 From $68, Keeps …

1 week from now

4 days ago · -- Biohaven has an average investment rating of buy among analysts polled by Capital IQ, with price targets ranging from $55 to $77. ...

marketscreener.com

$62
OFF

RBC Capital Starts Biohaven Stock With $62 PT, Cites Potential In ...

1 week from now

On Friday, RBC Capital Markets initiated coverage on shares of Biohaven Pharmaceutical Holding Company (NYSE:BHVN), assigning an Outperform rating with a price target of $62.00.

investing.com

$75
OFF

Biohaven Shares Rise As TD Cowen Lifts Price Target To $75

1 week from now

4 days ago · RBC (TSX: RY) Capital lowered Biohaven's stock price target from $68.00 to $66.00, maintaining an Outperform rating, following the company's third-quarter earnings report for …

investing.com

$68
OFF

Buy Rating On Biohaven: Breakthrough Potential With T-Alfa In …

1 week from now

Oct 8, 2024 · Biohaven price target raised to $68 from $55 at JPMorgan; 3 Best Stocks to Buy Now, 10/3/2024, According to Top Analysts ; ... Biohaven price target lowered to $66 from $68 …

businessinsider.com

$63.42
OFF

Biohaven (BHVN) Stock Forecast And Price Target 2024 - MarketBeat

1 week from now

4 days ago · BHVN's current price target is $63.42. Learn why top analysts are making this stock forecast for Biohaven at MarketBeat. ... According to the 14 analysts' twelve-month price …

marketbeat.com

$68
OFF

RBC Capital Maintains Outperform On Biohaven, Lowers Price …

1 week from now

4 days ago · RBC Capital analyst Leonid Timashev maintains Biohaven (NYSE:BHVN) with a Outperform and lowers the price target from $68 to $66.

sahmcapital.com

$68
OFF

RBC Raises Price Target On Biohaven To $68 From $59, Keeps …

1 week from now

Sep 24, 2024 · Biohaven Prices $250 Million Common Stock Offering Oct. 01: MT RBC Raises Price Target on Biohaven to $68 From $59, Keeps Outperform, Speculative Risk Sep. 24: MT …

marketscreener.com

FAQs about Biohaven price target lowered to $66 from $68 at RBC Capital Coupon?

Should you buy Biohaven Ltd (bhvn)?

In a report released yesterday, Thomas Shrader from BTIG maintained a Buy rating on Biohaven Ltd. (BHVN – Research Report), with a price target of $59.00. Thomas Shrader has given his Buy rating due to a combination of factors concerning the promising potential of Biohaven Ltd.’s therapeutic developments. ...

Where is Biohaven Ltd headquartered?

The company was founded on May 2, 2022 and is headquartered in New Haven, CT. View Biohaven Ltd. BHVN stock quote prices, financial information, real-time forecasts, and company news from CNN. ...

Why did Marc Goodman buy Biohaven Ltd?

Marc Goodman has given his Buy rating due to a combination of factors related to Biohaven Ltd.’s recent performance and future prospects. The company has reported its third-quarter results for 2024, showing promising progress in their pipeline. ...

Why did Thomas Shrader buy Biohaven Ltd?

Thomas Shrader has given his Buy rating due to a combination of factors concerning the promising potential of Biohaven Ltd.’s therapeutic developments. His confidence stems from the positive results of the SAPPHIRE trial for the treatment of SMA (Spinal Muscular Atrophy) with T-Alfa, a myostatin inhibitor. ...

What does Biohaven do?

Biohaven Ltd. is a global clinical stage biopharmaceutical company, which engages in the discovery, development, and commercialization of therapies for people with neurological and neuropsychiatric diseases. The company was founded on May 2, 2022 and is headquartered in New Haven, CT. ...

Does Biohaven offer Rimegepant for migraine?

Biohaven’s Neuroinnovation portfolio includes FDA-approved Nurtec ODT (rimegepant) for the acute and preventive treatment of migraine (EMA-approved as Vydura (rimegepant) for the acute treatment of migraine with or without aura, and prophylaxis of episodic migraine. ...